Timothy C Durazzo1,2, Linh-Chi Nguyen1,2, Dieter J Meyerhoff3,4. 1. Mental Illness Research and Education Clinical Centers, VA Palo Alto Health Care System, Palo Alto, CA, USA. 2. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. 3. Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco VA Medical Center, San Francisco, CA, USA. 4. Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
Abstract
AIMS: Magnetic resonance imaging (MRI) studies report widespread cortical thinning in individuals with alcohol use disorder (AUD), but did not consider potential effects of pro-atherogenic conditions such as hypertension, type 2 diabetes mellitus, hepatitis C seropositivity and hyperlipidemia on cortical thickness. The conditions are associated with regional cortical thinning in those without AUD. We predicted that individuals with concurrent AUD and pro-atherogenic conditions demonstrate the greatest regional cortical thinning in areas most vulnerable to decreased perfusion. METHODS: Treatment-seeking individuals with AUD (n = 126) and healthy controls (CON; n = 49) completed a 1.5 T MRI study. Regional cortical thickness was quantitated via FreeSurfer. Individuals with AUD and pro-atherogenic conditions (Atherogenic+), AUD without pro-atherogenic conditions (Atherogenic-) and CON were compared on regional cortical thickness. RESULTS: Individuals with AUD showed significant bilateral cortical thinning compared to CON, but Atherogenic+ demonstrated the most widespread and greatest magnitude of regional thinning, while Atherogenic- had reduced thickness primarily in anterior frontal and posterior parietal lobes. Atherogenic+ also showed a thinner cortex than Atherogenic- in lateral orbitofrontal and dorso/dorsolateral frontal cortex, mesial and lateral temporal and inferior parietal regions. CONCLUSIONS: Our results demonstrate significant bilateral cortical thinning in individuals with AUD relative to CON, but the distribution and magnitude were influenced by comorbid pro-atherogenic conditions. The magnitude of cortical thinning in Atherogenic+ strongly corresponded to cortical watershed areas susceptible to decreased perfusion, which may result in morphometric abnormalities. The findings indicate that pro-atherogenic conditions may contribute to cortical thinning in those seeking treatment for AUD.
AIMS: Magnetic resonance imaging (MRI) studies report widespread cortical thinning in individuals with alcohol use disorder (AUD), but did not consider potential effects of pro-atherogenic conditions such as hypertension, type 2 diabetes mellitus, hepatitis C seropositivity and hyperlipidemia on cortical thickness. The conditions are associated with regional cortical thinning in those without AUD. We predicted that individuals with concurrent AUD and pro-atherogenic conditions demonstrate the greatest regional cortical thinning in areas most vulnerable to decreased perfusion. METHODS: Treatment-seeking individuals with AUD (n = 126) and healthy controls (CON; n = 49) completed a 1.5 T MRI study. Regional cortical thickness was quantitated via FreeSurfer. Individuals with AUD and pro-atherogenic conditions (Atherogenic+), AUD without pro-atherogenic conditions (Atherogenic-) and CON were compared on regional cortical thickness. RESULTS: Individuals with AUD showed significant bilateral cortical thinning compared to CON, but Atherogenic+ demonstrated the most widespread and greatest magnitude of regional thinning, while Atherogenic- had reduced thickness primarily in anterior frontal and posterior parietal lobes. Atherogenic+ also showed a thinner cortex than Atherogenic- in lateral orbitofrontal and dorso/dorsolateral frontal cortex, mesial and lateral temporal and inferior parietal regions. CONCLUSIONS: Our results demonstrate significant bilateral cortical thinning in individuals with AUD relative to CON, but the distribution and magnitude were influenced by comorbid pro-atherogenic conditions. The magnitude of cortical thinning in Atherogenic+ strongly corresponded to cortical watershed areas susceptible to decreased perfusion, which may result in morphometric abnormalities. The findings indicate that pro-atherogenic conditions may contribute to cortical thinning in those seeking treatment for AUD.
Authors: Benjamin Rolland; Laurence Dricot; Coralie Creupelandt; Pierre Maurage; Philippe De Timary Journal: Addict Biol Date: 2019-04-09 Impact factor: 4.280
Authors: Reza Momenan; Leah E Steckler; Ziad S Saad; Stefanie van Rafelghem; Michael J Kerich; Daniel W Hommer Journal: Psychiatry Res Date: 2012-11-11 Impact factor: 3.222
Authors: Anderson M Winkler; Peter Kochunov; John Blangero; Laura Almasy; Karl Zilles; Peter T Fox; Ravindranath Duggirala; David C Glahn Journal: Neuroimage Date: 2009-12-16 Impact factor: 6.556
Authors: Nikos Makris; Gregory P Gasic; David N Kennedy; Steven M Hodge; Jonathan R Kaiser; Myung Joo Lee; Byoung Woo Kim; Anne J Blood; A Eden Evins; Larry J Seidman; Dan V Iosifescu; Sang Lee; Claudia Baxter; Roy H Perlis; Jordan W Smoller; Maurizio Fava; Hans C Breiter Journal: Neuron Date: 2008-10-09 Impact factor: 17.173
Authors: Michael L Alosco; John Gunstad; Beth A Jerskey; Xiaomeng Xu; Uraina S Clark; Jason Hassenstab; Denise M Cote; Edward G Walsh; Donald R Labbe; Richard Hoge; Ronald A Cohen; Lawrence H Sweet Journal: Brain Behav Date: 2013-09-10 Impact factor: 2.708